{"first_name":"Michael","last_name":"Courtney","permalink":"michael-courtney","crunchbase_url":"http://www.crunchbase.com/person/michael-courtney","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Tue Jun 09 07:12:07 UTC 2009","updated_at":"Tue Jun 09 07:12:39 UTC 2009","overview":"<p>Michael Courtney, PhD, formerly Vice President &amp; Chief Scientific Officer of Transgene (Strasbourg) from 1991 to 2001. Transgene is a major public French biotechnology company developing immunotherapy-based products in oncology and infectious diseases. Michael was Executive Vice President and Chief Operating Officer at Noxxon Pharma AG, (Berlin), from 2001 to 2003 and Chief Executive Officer of Aptanomics (Lyon) from 2003 to 2007. He has a broad international experience in R&amp;D of Pharma products, in building strategic alliances and in Company financing including with Transgene, an IPO of over 100 million dollars&#8230;He is the author of more than 70 publications in international scientific and medical journals. Michael Courtney is responsible for the strategic leadership of CellVir.</p>","image":null,"degrees":[],"relationships":[{"is_past":false,"title":"Chairman","firm":{"name":"CellVir","permalink":"cellvir","type_of_entity":"company","image":{"available_sizes":[[[125,60],"assets/images/resized/0004/7580/47580v1-max-150x150.jpg"],[[125,60],"assets/images/resized/0004/7580/47580v1-max-250x250.jpg"],[[125,60],"assets/images/resized/0004/7580/47580v1-max-450x450.jpg"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}